Premier Gold Offers to Purchase Centerra’s 50% Stake in Greenstone Gold Mines Partnership
Premier Gold Mines Ltd (TSX: PG), through its assignee, has offered to purchase Centerra Gold Inc (TSX: CG)‘s 50% interest in the Greenstone Gold Mines Partnership for the amount of $205 million USD. The Hardrock Mine Project, which is located in Ontario, is the Greenstone Gold Mines Partnership (GGM) primary asset. The large-scale mining operation […]
Experion Receives Amendment to Increase Processing and Cultivation Capacity
Experion Holdings Ltd (TSXV: EXP), through its wholly-owned subsidiary, Experion Biotechnologies has been granted an amendment for its Health Canada license to increase capacity at the company’s facility located in Mission, British Columbia. Effective immediately, the licencing amendment will allow Experion to increase cultivation capacities by 20%, with which the company plans to grow cannabis […]
Cronos Group Posts Revenues of US$7.3 Million For Q4 2019, Loss of US$63.8 Million
Cronos Group (TSX: CRON) (NASDAQ: CRON) has finally reported its fourth quarter and full fiscal year 2019 financial results after delaying earnings twice previously. Notably, the company has switched from reporting in Canadian Dollars to that of US Dollars. For the fourth quarter, the company reported revenues of US$7.3 million (C$10.3 million). Revenues for the […]
CloudMD Closes Financing, Raising $3.02 Million In Aggregate
CloudMD Software & Services (CSE: DOC) this morning has closed the second and final tranche of its previously announced private placement lead by Gravitas Securities. The tranche consisted of a total $683,199.68 in funds for the telemedicine focused firm. In total, the financing conducted resulted in the sale of 6,298,615 units at a price per […]
HIVE Blockchain Enters Into Agreement to Acquire Cryptologic’s Quebec Mining Operation
HIVE Blockchain Technologies Inc (TSXV: HIVE) has entered into a definitive agreement to acquire a cryptocurrency mining operation from Cryptologic Corp (CSE: CRY). HIVE has signed an agreement to acquire Cryptologic’s cryptocurrency mining operation located in Lachute, Quebec. This leased facility has access to 30 megawatts of HVAC and green power, electricity costs of US$0.04/kWh, […]
Eve & Co Accepts CFO Resignation
Eve & Co Incorporated (TSXV: EVE) has announced the resignation of the company’s Chief Financial Officer, Landon Roedding. Landon Roedding has been with Eve & Co since October 2018, but on March 30, 2020, the company announced that he has submitted his resignation. The Board of Directors have since appointed Rory Taylor as Interim Chief […]
MediPharm Labs Report sees Quarterly Revenue Drop 25%
This morning MediPharm Labs (TSX: LABS) released their fourth quarter results for the year ended December 31, 2019. The quarter saw revenues decline approximately 25.4% from the previous quarter with a 73.6% decline in Adjusted EBITDA over the same period. The previously beloved cannabis market darling saw a decline in pretty much everything on a […]
Tinley To See Final Inspections Occur At Long Beach This Week
The Tinley Beverage Company (CSE: TNY) released an update in connection with it’s much anticipated Long Beach, California facility this morning, identifying that the much awaited electrical inspection has been completed for the flagship facility. The inspection follows the completion of the install of much needed specialized electrical infrastructure for the facility, which now enables […]
Hexo Posts Net Loss of $298.2 Million, Effectively Writes Off Newstrike Transaction
Hexo Corp (TSX: HEXO) (NYSE: HEXO) released its second quarter financials this morning, in what might be referred to as a “kitchen sink” quarter given how much the company has impaired in terms of assets. Total net loss for the quarter came in at $298.2 million as a result of the cumulative write offs and […]
Revive Seeks To Advance Bucillamine Study To Phase 2 Clinical Study
This morning, Revive Therapeutics (CSE: RVV) released an update in relation to its ongoing study of Bucillamine for the use as a treatment against infectious diseases. The company intends to conduct human clinical trials in regions where the company has regulatory approval to investigate in clinical studies, which includes both the United States as well […]